Collaboration as the key to turning around the drug discovery business (Part 2) – The Hypothesis
August 7, 2011
Challenges facing individual researchers and drug discovery organizations could potentially be addressed en masse if collaborative processes and technologies were embraced to realize the economic benefits of well-integrated specialization. Collaborative capabilities (when well developed, implemented, & adopted), allow multiple individuals to combine various ideas and perspectives, as if they were all coherently contained in a single brain. Collaborative capabilities (when well developed, implemented, & adopted) with secure data partitioning capabilities “in the cloud” allow multiple specialized organizations, to work naturally, as if one company.
For full context, find the link to each entry of our 12-part series, “Collaboration is the Key to Turning Around the Drug Discovery Business” using the links below:
Especially read Part 9: Collaboration as the key to turning around the drug discovery business – Collaborate Better
P.S. Beyond collaboration as a more enlightened approach to science, here are the top 5 practical reasons collaborative scientists rock with CDD: 5 Reasons Why Collaborative Scientists Use CDD
You can also download the full series “Collaboration as the key to turning around the drug discovery business” by Barry Bunin as a pdf document:
This blog is authored by members of the CDD Vault community. CDD Vault is a hosted drug discovery informatics platform that securely manages both private and external biological and chemical data. It provides core functionality including chemical registration, structure activity relationship, chemical inventory, and electronic lab notebook capabilities!
CDD Vault: Drug Discovery Informatics your whole project team will embrace!